This podcast episode explores the use of surrogate endpoints versus patient-important clinical outcomes in medical and psychological research studies, highlighting their role in accelerating trials while cautioning against over-reliance. It presents advantages such as faster, less expensive studies alongside critical limitations, including frequent failures to predict real clinical benefit as seen in cardiovascular, oncology, and Alzheimer’s research. Listeners receive a balanced framework for critically appraising research that employs surrogate markers.